← Back to Search

Classroom Behavior Support for ADHD (CBS Trial)

N/A
Waitlist Available
Research Sponsored by Ohio University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Must not have
Student with special education eligibility of cognitive disability, autism, or multiple disability.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up growth from baseline to one year following study completion, an average of 18 months
Awards & highlights

Summary

This trial will compare a new classroom management program against best practices to see if it has an impact on student behavioral and educational outcomes.

Who is the study for?
This trial is for elementary school teachers (K-6th grade) who have at least one student spending more than half the day in their class and showing signs of ADHD. Teachers must be observed with specific classroom management challenges, such as low response to rule violations or below-average praise rates. Parental consent for student participation is required.
What is being tested?
The study tests a Classroom Behavior Support Program aimed at improving teacher's management skills and students' behavior/education outcomes, compared to standard problem-solving consultations. Participants are randomly assigned to either the CBS program or a comparison group.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional side effects are not applicable. However, there may be unintended consequences on classroom dynamics or individual student behavior due to changes in teaching strategies.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am a student eligible for special education due to cognitive disability, autism, or multiple disabilities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~growth from baseline to one year following study completion, an average of 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and growth from baseline to one year following study completion, an average of 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Target Student Rule Violations (Tier 2 Student Outcome)
Teacher Percent Appropriate Response to Rule Violation (ARRV) - Target Student (Tier 2 Teacher Outcome)
Teacher Percent Appropriate Response to Rule Violation (ARRV) - Whole Class (Tier 1 Teacher Outcome)
+1 more
Secondary study objectives
Parent Ratings of Target Student ADHD Symptoms - (Tier 2 Student Outcome)
Parent Ratings of Target Student Behavior - (Tier 2 Student Outcome)
Target Student Grade Point Average (GPA) Intervention Year - (Tier 2 Student Outcome)
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Classroom Behavior Support (CBS) ConditionExperimental Treatment1 Intervention
Consultants follow the problem-solving process used in the comparison condition and attempt to address barriers to integrity using the knowledge, skills, beliefs, or stress components in the CBS manual. Consultants conduct a Values Interview, so teacher values can be used in the individual goal setting and decision making process. Consultants are trained to (a) incorporate the teacher's values into the problem-solving process, (b) elicit change talk from teachers using techniques borrowed from Motivational Interviewing, and (c) engage in Socratic questioning and cognitive restructuring for beliefs that may be barriers to integrity (e.g., "should" statements). Enhanced performance feedback involves highlighting connections between teacher integrity and child outcomes and using this as a catalyst for a knowledge, skills, beliefs, or stress component. Consultants use change rulers to elicit motivation to achieve the stated goals.
Group II: Standard Problem Solving Comparison ConditionActive Control1 Intervention
Consultation in the comparison condition follows a 5-step problem solving approach and provide brief performance feedback procedures that mirror (in duration, content, and process) best practice procedures (Gilbertson et al., 2007; Noell et al., 1997). The guiding principles for this condition are that the performance feedback portion of the session should be limited to 5 to 10 minutes and unless the teacher initiates discussion of other content, the problem solving should remain student-focused, rather than teacher-focused. Discussion on teacher values and beliefs, and attempts to facilitate change talk, are contra-indicated. If the teacher initiates discussion of knowledge, beliefs, or skills, the consultant may answer questions, but may not use strategies associated with Motivational Interview or Cognitive-Behavioral Therapy (CBT) or strategies in CBS condition. We have separate scripts and checklists for each condition.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Classroom Behavior Support (CBS) Condition
2021
N/A
~130

Find a Location

Who is running the clinical trial?

Ohio UniversityLead Sponsor
70 Previous Clinical Trials
37,073 Total Patients Enrolled
3 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
243 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Media Library

Classroom Behavior Support (CBS) Condition Clinical Trial Eligibility Overview. Trial Name: NCT05137327 — N/A
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: Classroom Behavior Support (CBS) Condition, Standard Problem Solving Comparison Condition
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: Classroom Behavior Support (CBS) Condition Highlights & Side Effects. Trial Name: NCT05137327 — N/A
Classroom Behavior Support (CBS) Condition 2023 Treatment Timeline for Medical Study. Trial Name: NCT05137327 — N/A
~31 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top